SEC Form D · filed April 4, 2018
Arix Bioscience plc
Industry
Other Health Care
Location
LONDON, United Kingdom
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Franz Humer · LONDON, United KingdomDirectorJonathan Peacock · LONDON, United KingdomExec · DirectorDavid U'Prichard · LONDON, United KingdomDirectorTrevor Jones · LONDON, United KingdomDirectorJames Rawlingson · LONDON, United KingdomExec · DirectorJoseph Anderson · LONDON, United KingdomExec · DirectorChristopher Evans · LONDON, United KingdomExec · DirectorCarlos E. Ponte · Vancouver, British Columbia, CanadaExec · DirectorWillem Fuchter · Vancouver, British Columbia, CanadaDirectorPatrick E. Williams · La Veta, COExec · DirectorZula E. Kropivnitski · Vancouver, British Columbia, CanadaDirectorEduardo E. Perlicz · Vancouver, British Columbia, CanadaDirectorCassandra E. Gee · Vancouver, British Columbia, CanadaExec · DirectorHernan M. Zaballa · Vancouver, British Columbia, CanadaExec · DirectorJohn Hutton Of Furness · LONDON, United KingdomDirectorMeghan M. Fitzgerald · LONDON, United KingdomDirectorGiles M. Kerr · LONDON, United KingdomDirectorGlenn E. Martin · Tucson, AZExec · DirectorNicole M. Breen · Tucson, AZExec · DirectorYosef Katz · Cedarhurst, NYExec · DirectorRyan Krafft · Sherborn, MADirectorLindsey Krystofiak · SAN FRANCISCO, CADirectorThomas E. Willingham · Richmond, VADirectorAslam Merchant · ATLANTA, GAExec · DirectorJohn Hutton Of Furness · LONDON, United KingdomDirectorMeghan M. Fitzgerald · LONDON, United KingdomDirectorGiles M. Kerr · LONDON, United KingdomDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗